+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Stone Management Devices: Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1882054

Global Kidney Stone Management Devices Market to Reach $2.3 Billion by 2030

The global market for Kidney Stone Management Devices estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030. Ureteroscopy, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lithotripsy segment is readjusted to a revised 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $430.8 Million, While China is Forecast to Grow at 8.1% CAGR

The Kidney Stone Management Devices market in the U.S. is estimated at US$430.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$494.5 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$309.9 Million by the year 2030.

Select Competitors (Total 48 Featured) -

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Rise in incidence of Urolithiasis Drives Demand for Kidney Stone Management Devices Demand
  • Key Market Drivers
  • Market Restraints
  • Recent Market Activity
  • Kidney Stone Management Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Kidney Stone Management Devices Competitor Market Share Scenario Worldwide (in %): 2018 & 2025
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
  • Becton Dickinson and Company (USA)
  • Boston Scientific Corporation (USA)
  • Coloplast Group (Denmark)
  • Cook Medical (USA)
  • DirexGroup (Germany)
  • Dornier MedTech (Germany)
  • EDAP TMS SA (France)
  • E.M.S. Electro Medical Systems S.A. (Switzerland)
  • Lumenis Ltd. (Israel)
  • New Star Lasers, Inc. (USA)
  • Olympus Corp. (Japan)
  • Richard Wolf GmbH (Germany)
  • Siemens Healthineers (Germany)
  • Storz Medical AG (Switzerland)
3. MARKET TRENDS & DRIVERS
  • Developed Regions Dominate the Market
  • Emerging Countries Offer Brighter Growth Prospects
  • A Peek into Incidence and Prevalence of Urolithiasis
  • Noteworthy Trends
  • Rise in Popularity of 'Tubeless' Percutaneous Nephrolithotomy
  • Flexible Ureteroscopes Drive Adoption of Intracorporeal Ureteroscopy
  • ESWL Sustains Growth amid Other Alternative Treatment Approaches
  • Dornier MedTech Unveils World's First Smart Lithotripter
  • Manufacturers Focus on Development of Lithotripters for Small Hospitals
  • Rise in Demand for Holmium Lasers
  • Demand for Ureteral Stents remains Steady
  • Demographic Factors Influence Urological Devices Market
  • Rising Tide of Lifestyle Diseases - The Grim Reality Fueling Growth in Renal Diseases
  • Global Diabetic Statistics - Opportunity Indicators
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for Ureteroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 12: World 18-Year Perspective for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 15: World 18-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 18: World 18-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 21: World 18-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 22: World Kidney Stone Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 25: USA 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: USA Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 28: USA 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 31: Canada 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 34: Canada 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
JAPAN
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 37: Japan 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 40: Japan 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
CHINA
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 43: China 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: China Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 46: China 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
EUROPE
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 49: Europe 18-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 52: Europe 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 55: Europe 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
FRANCE
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 58: France 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: France Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 61: France 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
GERMANY
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 64: Germany 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 67: Germany 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 70: Italy 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 73: Italy 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
UNITED KINGDOM
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 76: UK 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: UK Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 79: UK 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 82: Spain 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 85: Spain 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 88: Russia 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 91: Russia 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 94: Rest of Europe 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 97: Rest of Europe 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
ASIA-PACIFIC
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 100: Asia-Pacific 18-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 103: Asia-Pacific 18-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2012, 2023 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 106: Asia-Pacific 18-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2012, 2023 & 2030
AUSTRALIA
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

Table Information